The authors of A different paper described the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven].Built-in data logging modules file controlled and measured info and supply useable success information. As with all testing at our